Douglas Powell

Company: Crown Bioscience

Job title: Director, Scientific Engagement

Seminars:

Leveraging PDX-derived Organoid (PDXO) Models for Combination Targeted Oncology 8:30 am

PDX-derived organoids are biologically equivalent to their matched PDX counterparts based on several shared characteristics Screening of PDXO in a combination matrix approach enables rapid and valuable insight into combination strategies A PDXO in vitro platform improves translatability of drug candidates, saves development time, and reduces animal usage by guiding optimal in vivo model selection…Read more

day: Day One